Browse Category

Investment Insights News 14 December 2025 - 15 December 2025

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation stock is back in the spotlight on December 15, 2025, as the cannabis sector reacts to a fresh wave of reporting that President Donald Trump may soon move to ease federal marijuana restrictions—specifically by reclassifying cannabis as
Reliance Industries Share Price Today (15 December 2025): What’s Driving RIL Stock, Latest News, and Analyst Targets

Reliance Industries Share Price Today (15 December 2025): What’s Driving RIL Stock, Latest News, and Analyst Targets

Reliance Industries Limited (RIL) shares were trading largely steady on Monday, 15 December 2025, hovering around the ₹1,55x zone and staying within striking distance of their recent 52-week high as investors weighed a busy mix of catalysts—fresh FMCG acquisition chatter,
Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. (NASDAQ: FRMI) stock plunged after a prospective tenant terminated a $150M construction funding agreement tied to Project Matador. Here’s the latest news, forecasts, and analyst outlook as of Dec. 14, 2025. Published/Updated: Sunday, December 14, 2025 (markets closed;
1 26 27 28 29 30 57
Go toTop